Hwee Teoh

16PUBLICATIONS
48CO-AUTHORS
Molecular targetsCardiovascular medicine and haematology not elsewhere classifiedCheminformatics and quantitative structure-activity relationshipsCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 16, 2026
Prevention of Vascular Aging as a Novel Paradigm for GLP-1 Receptor Agonist-Mediated Cardioprotection.

|Mar 31, 2026
Relationship Between Achieved LDL-C and Saphenous Vein Graft Patency: A Post Hoc Analysis of the NEWTON-CABG CardioLink-5 Study.

Michael Szarek, Lawrence A Leiter, Hwee Teoh

|Sep 03, 2025
The Emerging Role of Aldosterone Synthase Inhibitors in Overcoming Renin-Angiotensin-Aldosterone System Therapy Limitations: A Narrative Review.

Shubh K Patel, Hwee Teoh, Ahreni Saunthar

|Aug 31, 2025
Semaglutide promotes bone marrow-derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial.

Brady Park, Fallon Dennis, Arianna Z He

|Aug 29, 2025
Vascular regenerative deficiencies in people with elevated lipoprotein(a): the Lp(a)-VRCE CardioLink-16 translational study.

Michael Moroney, Jack H Casey, Hwee Teoh

|Jun 14, 2024
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes.

Brady Park, Aishwarya Krishnaraj, Hwee Teoh

Pageof 3

Frequent Collaborators

16 joint publications

Subodh Verma

11 joint publications

Adrian Quan

10 joint publications

Cyril David Mazer

8 joint publications

David A Hess